Trial Profile
Ropinirole in patients with depressive symptoms and restless legs syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Depression; Restless legs syndrome
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 05 Nov 2010 New trial record.